NASDAQ:SGP Spyglass Pharma Q4 2025 Earnings Results & Report $24.92 +0.30 (+1.22%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$25.11 +0.19 (+0.76%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Spyglass Pharma beat analyst earnings expectations in its Q4 2025 results, released March 26, 2026. The company reported EPS of -$5.72 versus the -$6.61 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2025Report DateMarch 26, 2026TimeAfter Market ClosesConference Call4:00 PM ET Spyglass Pharma EPS ResultsActual EPS-$5.72Consensus EPS -$6.61Beat/MissBeat by +$0.89One Year Ago EPSN/ASpyglass Pharma Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Annual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Annual report(10-K) Spyglass Pharma Q4 2025 Earnings FAQ Did Spyglass Pharma beat earnings estimates for Q4 2025? Spyglass Pharma (NASDAQ:SGP) reported earnings of -$5.72 per share for Q4 2025, beating the consensus estimate of -$6.61. The report was announced on Thursday, March 26, 2026. Spyglass Pharma Earnings HeadlinesSpyGlass Pharma closes AVS buy for $13 millionOctober 4, 2026 | americanbankingnews.comWall Street Zen Downgrades Spyglass Pharma (NASDAQ:SGP) to SellOctober 3, 2026 | americanbankingnews.comIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live.October 10 at 1:00 AM | Banyan Hill Publishing (Ad)SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion CapabilityOctober 1, 2026 | globenewswire.comSpyglass Pharma, Inc. (NASDAQ:SGP) Stock Now Rated "Moderate Buy" by Wall Street AnalystsOctober 1, 2026 | americanbankingnews.comSpyGlass Pharma, Inc. (SGP) Presents at Citigroup's Biopharma Back to School Summit 2026 TranscriptSeptember 10, 2026 | seekingalpha.comSee More Spyglass Pharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Spyglass Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spyglass Pharma and other key companies, straight to your email. Email Address About Spyglass PharmaSpyglass Pharma (NASDAQ:SGP) is a clinical-stage ophthalmic pharmaceutical company developing sustained-release drug-delivery technologies for the treatment of eye diseases. The company’s platform is designed to deliver medication inside the eye over extended periods, with the goal of reducing reliance on daily eye drops and improving treatment adherence. SpyGlass Pharma’s lead development programs focus on glaucoma and ocular hypertension, conditions in which elevated intraocular pressure can damage the optic nerve and lead to vision loss. Its portfolio includes intraocular implant candidates designed to provide controlled delivery of established ophthalmic medicines, including bimatoprost, over an extended period. The company conducts its research and clinical development activities primarily in the United States. SpyGlass Pharma is focused on advancing its implant-based therapies through clinical development and regulatory evaluation; detailed information about its broader commercial operations and leadership is limited.View Spyglass Pharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
